In a hearing on the petition filed by Dabur against Patanjali Ayurveda, Dabur has completed presenting its arguments. The Delhi High Court, led by Justice Mini Pushkarna, is hearing the case, with Patanjali scheduled to present its side on January 27.
During the proceedings, Dabur’s lawyer argued that Patanjali’s Chyawanprash contains mercury, which, according to Dabur, is harmful, especially for children.
Dabur also pointed out that Patanjali has failed to provide a legal disclaimer regarding the presence of mercury in its product. It also filed the petition, alleging that Patanjali has been running misleading advertisements targeting Dabur’s Chyawanprash.
Dabur has requested the Delhi High Court to order Patanjali to immediately stop broadcasting or publishing derogatory advertisements against its products. The petition claims that Patanjali’s advertisements mislead consumers into believing that only Patanjali’s Chyawanprash adheres to the traditional formulations of ancient Ayurvedic texts.
When Dabur initially filed its petition, the Delhi High Court considered referring the matter for mediation. However, after Dabur insisted on urgent relief, the court decided to hear the case directly.
Senior advocate Akhil Sibal, representing Dabur, described Patanjali Ayurveda as a “habitual offender” in misleading advertising. Sibal also referenced a recent Supreme Court ruling in a contempt petition filed against Patanjali, which led to Patanjali, Baba Ramdev, and Acharya Balkrishna issuing written apologies published in newspapers.
Sibal emphasized that all Chyawanprash products should adhere to the specific formulations and ingredients outlined in ancient Ayurvedic texts, claiming that Patanjali’s advertisements mislead consumers and harm competitors like Dabur, which holds a 61.6 percent market share in the segment.
At the heart of the dispute is an advertisement featuring Patanjali Ayurveda founder Baba Ramdev. In the ad, Ramdev asserts that only Patanjali’s Chyawanprash is the “original” and that other manufacturers lack knowledge of traditional Ayurvedic formulations. Dabur has objected to this claim, arguing that it unfairly disparages other Chyawanprash products.
This isn’t the first time Patanjali has faced legal challenges over its advertising. In 2017, the Delhi High Court banned Patanjali Ayurveda from broadcasting or publishing any advertisements for its Chyawanprash products, citing misleading claims.
With Dabur’s arguments now concluded, the next phase of the hearing will see Patanjali Ayurveda defending its position. The Delhi High Court’s decision will likely have significant implications for advertising practices in the Indian consumer goods market.
Also Read: Supreme Court Rejects PIL To Abolish TDS System, Suggests High Court Approach
Refusing to grant any relief to a Sri Lankan national facing possible deportation, the Supreme…
Due to continuing tensions with Pakistan, the Board of Control for Cricket in India (BCCI)…
India now exports seafood to 130 countries, up from 105 in 2014-15, reflecting the expanding…
Significantly, ICRA called the FTA a game-changer for both countries. “Trade is expected to double…
India has retained its position as the world’s largest market for electric three-wheelers (3Ws) for…
India’s pharmaceutical sector continues to rise on the global stage, driven by innovation, affordability, and…